Purchase Order 75N93024P00145
Award Date 1/5/24
Potential Completion Date 1/4/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions. The $13,250.00 contract is for a MiSeq Silver Support Plan, with a completion date of September 25, 2020. Illumina has previously received prime federal contracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $48,209 firm fixed price purchase order to Illumina, Inc. to provide two Nextseq 2000 Silver Support Plans. The solicitation sought comparable services to support NIAID's genomic research efforts, including full parts, labor, and travel coverage; reagent replacement for hardware failures; remote and on-site technical support; software and...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $36,117 firm fixed price purchase order to Illumina, Inc. to provide a NEXTSEQ 1000 SILVER SUPPORT PLAN. The place of performance is Potomac, Maryland and the period of performance is from December 1, 2023 through November 30, 2024. This support plan is likely associated with the NIH's ongoing genomic sequencing and bioinformatics research efforts to...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $213,150 firm fixed price purchase order to Illumina, Inc. to deliver a NextSeq 1000 Sequencing System. The award was made under simplified acquisition procedures solicitation number RFQ-NIH-NIAID-2183146, which sought quotes for the sequencing system as well as its delivery to NIH in Bethesda, Maryland, installation, setup, operator training, and maintenance/support services. The...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
- This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,171 firm fixed price purchase order to Illumina, Inc. for the annual renewal of the NextSeq bronze support plan. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver maintenance services for the NextSeq sequencing system located in Rockville, Maryland under this contract. No set-aside provision was utilized for this...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $53,029.50 firm-fixed price purchase order to Illumina, Inc. for a one-year service plan covering preventative maintenance, full parts and labor coverage, reagent replacement, remote technical support, and software/hardware updates for the agency's Illumina NextSeq 2000 sequencing equipment at their Laboratory of Viral Diseases. This purchase was made under full and...